RSV-induced immunopathology: Dynamic interplay between the virus and host immune response

Virology

Volumn 295, Issue 2, 2002, Pages 203-207

  Varga, Steven M ^a   Braciale, Thomas J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FI RESPIRATORY SYNCYTIAL VIRUS VACCINE; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBODY TITER; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOPATHOLOGY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EFFECTOR CELL; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOLOGY; INFECTION PREVENTION; LOEFFLER PNEUMONIA; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MORBIDITY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; SHORT SURVEY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION; VACCINE PRODUCTION; VIRUS GENOME; VIRUS IMMUNITY;

PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 0036066343     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1382     Document Type: Article

References (36)

1. Phenotypic analysis of antigen-specific T lymphocytes
2. Distinct types of lung disease caused by functional subsets of antiviral T cells
3. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins
4. + T cells
5. Parenteral administration of live respiratory syncytial virus vaccine: Results of a field trial
6. + T-cell memory in the respiratory tract
7. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population
8. + T cells
9. Accessing complexity: The dynamics of virus-specific T cell responses
10. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults
11. Respiratory syncytial virus and influenza A infections in the hospitalized elderly
12. Viral respiratory infections in the institutionalized elderly: Clinical and epidemiologic findings
13. Chronic soluble antigen sensitization primes a unique memory/effector T cell repertoire associated with Th2 phenotype acquisition in vivo
14. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine
15. Risk of primary infection and reinfection with respiratory syncytial virus
16. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice
17. An outbreak of respiratory syncytial virus in a bone marrow transplant center
18. Respiratory syncytial and parainfluenza viruses
19. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection
20. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge
21. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine
22. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
23. Respiratory syncytial virus infection in the elderly
24. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
25. d-restricted cytotoxic T lymphocytes from mice primed by infection
26. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G
27. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia
28. + T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection
29. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection
30. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent
31. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus
32. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus
33. d-restricted peptides
34. + T cells
35. + T cell responses
36. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern